Table 2.
Clinicopathological data of CRbCs and poorly differentiated medullary carcinomas (PDMC) included in our study.
| Cases | Gender | Age | Site | Size (cm) | Type | Metastases | Stage | Treatment | Outcome * |
|---|---|---|---|---|---|---|---|---|---|
| CRbC 1 | F | 63 | Hepatic flexure | 10 | Pure | N | IIIC | Surgery | 2 months |
| CRbC 2 | F | 76 | Sigmoid colon | 4 | Pure | - | - | Surgery + CT | 7 months |
| CRbC 3 | M | 85 | Splenic flexure | 6 | Pure | N, L | IVA | Surgery | 2 months |
| CRbC 4 | M | 65 | Cecum | 6 | Pure | N | IIIB | Surgery | 216 months (alive) |
| CRbC 5 | M | 63 | Rectum | 6 | Pure | N | IIIC | Surgery | 10 months |
| CRbC 6 | M | 64 | Hepatic flexure | 6 | Combined | N | IIIB | Surgery | - |
| CRbC 7 | F | 77 | Ascending colon | 7 | Combined | absence | IIA | Surgery | 187 months (alive) |
| PDMC 1 | M | 79 | Ascending colon | 10 | - | N | IIIC | Surgery | 11 months |
| PDMC 2 | F | 94 | Ascending colon | 8 | - | N | IIIC | Surgery | 5 months |
| PDMC 3 | F | 53 | Sigmoid colon | 13 | - | N | IIIC | Surgery | - |
| PDMC 4 | M | 73 | Cecum | 8 | - | N | IIIC | Surgery | 124 months (alive) |
Legend: F—female; M—male; N—lymph node; L—liver; CT—chemotherapy, (-)—data not available; * time from diagnosis to death was reported or to the last follow-up if the patient was alive.